The goal of the study is to obtain preliminary data that will test whether the antidepressant
medication escitalopram resets the body clock: a collection of nerve cells in the brain that
control the timing of many body processes. The study will also test whether the improvement
in depression symptoms with escitalopram correlates with the degree to which the timing of
the body clock is properly aligned with the timing of sleep.